title: Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
authors: Division Of PET Imaging, Molecular Imaging and Research Centre, Institute of Nuclear Medicine and Allied Sciences, Delhi, India. madhu_deven@yahoo.com
authors: Madhavi
authors: M
authors: Tripathi
authors: Madhur
authors: M
authors: Srivastava
authors: Gunjun
authors: G
authors: Garg
authors: Abhinav
authors: A
authors: Jaimini
authors: Namita
authors: N
authors: Singh
authors: Maria D
authors: MD
authors: Souza
authors: Prabhjot
authors: P
authors: Kaur
authors: Rajnish
authors: R
authors: Sharma
authors: Anupam
authors: A
authors: Mandal
mesh_terms: D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D007889:Leiomyoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D009215:Myometrium / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014057:Tomography, X-Ray Computed; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D004965:Estrogen Antagonists; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003613:Danazol